-
1دورية أكاديمية
المؤلفون: Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, ROADMAP Trial Investigators
المساهمون: SCHEEN, André
المصدر: New England Journal of Medicine, 364, 907-917 (2011)
مصطلحات موضوعية: Albuminuria/epidemiology/*prevention & control, Angiotensin II Type 1 Receptor Blockers/adverse effects/*therapeutic use, Blood Pressure/drug effects, Cardiovascular Diseases/epidemiology/etiology/mortality, Coronary Disease/complications, Diabetes Mellitus, Type 2/complications/*drug therapy, Human health sciences, Endocrinology, metabolism & nutrition, Urology & nephrology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Urologie & néphrologie
العلاقة: http://www.nejm.orgTest/; urn:issn:0028-4793; urn:issn:1533-4406; https://orbi.uliege.be/handle/2268/98960Test; info:hdl:2268/98960; https://orbi.uliege.be/bitstream/2268/98960Test/1/Olmesartan%20for%20the%20Delay%20or%20Prevention.pdf; scopus-id:2-s2.0-79952373965; info:pmid:21388309
الإتاحة: https://doi.org/10.1056/NEJMoa1007994Test
https://orbi.uliege.be/handle/2268/98960Test
https://orbi.uliege.be/bitstream/2268/98960Test/1/Olmesartan%20for%20the%20Delay%20or%20Prevention.pdf -
2دورية أكاديمية
المؤلفون: McMurray, John J, Holman, Rury R, Haffner, Steven M, Bethel, M Angelyn, Holzhauer, Bjorn, Hua, Tsushung A, Belenkov, Yuri, Boolell, Mitradev, Buse, John B, Buckley, Brendan M, Chacra, Antonio R, Chiang, Fu*-Tien, Charbonnel, Bernard, Chow, Chun*-Chung, Davies, Melanie J, Deedwania, Prakash, Diem, Peter, Einhorn, Daniel, Fonseca, Vivian, Fulcher, Gregory R, Gaciong, Zbigniew, Gaztambide, Sonia, Giles, Thomas, Horton, Edward, Ilkova, Hasan, Jenssen, Trond, Kahn, Steven E, Krum, Henry, Laakso, Markku, Leiter, Lawrence A, Levitt, Naomi S, Mareev, Viacheslav, Martinez, Felipe, Masson, Chantal, Mazzone, Theodore, Meaney, Eduardo, Nesto, Richard, Pan, Changyu, Prager, Rudolf, Raptis, Sotirios A, Rutten, Guy E H M, Sandstroem, Herbert, Schaper, Frank, Scheen, André, Schmitz, Ole, Sinay, Isaac, Soska, Vladimir, Stender, Steen, Tamas, Gyula, Tognoni, Gianni, Tuomilehto, Jaako, Villamil, Alberto S, Vozar, Juraj, Califf, Robert M
المصدر: New England Journal of Medicine, 362 (16), 1477-90 (2010)
مصطلحات موضوعية: Angiotensin II Type 1 Receptor Blockers/adverse effects/therapeutic use, Blood Glucose/analysis/drug effects, Blood Pressure/drug effects, Body Weight/drug effects, Cardiovascular Diseases/epidemiology/mortality/prevention & control, Cyclohexanes/therapeutic use, Diabetes Mellitus, Type 2/epidemiology/prevention & control, Double-Blind Method, Drug Therapy, Combination, Exercise, Female, Follow-Up Studies, Glucose Intolerance/diet therapy/drug therapy/therapy, Humans, Hypoglycemic Agents/therapeutic use, Incidence, Male, Middle Aged, Phenylalanine/analogs & derivatives/therapeutic use, Proportional Hazards Models, Risk Factors, Tetrazoles/adverse effects/therapeutic use, Valine/adverse effects/analogs & derivatives/therapeutic use, Human health sciences, Endocrinology, metabolism & nutrition, Cardiovascular & respiratory systems, Pharmacy
العلاقة: http://www.nejm.orgTest; urn:issn:0028-4793; urn:issn:1533-4406; https://orbi.uliege.be/handle/2268/25987Test; info:hdl:2268/25987; https://orbi.uliege.be/bitstream/2268/25987Test/1/Effect%20of%20Valsartan%20on%20the%20Incidence.pdf; scopus-id:2-s2.0-77951453096; info:pmid:20228403
الإتاحة: https://doi.org/10.1056/NEJMoa1001121Test
https://orbi.uliege.be/handle/2268/25987Test
https://orbi.uliege.be/bitstream/2268/25987Test/1/Effect%20of%20Valsartan%20on%20the%20Incidence.pdf